Evidence map›Paper›PMID 29305462›Full record

ArticleScience immunology2018

Type I interferons instigate fetal demise after Zika virus infection.

Laura J Yockey, Kellie A Jurado, Nitin Arora, Alon Millet, Tasfia Rakib, Kristin M Milano, Andrew K Hastings, Erol Fikrig, Yong Kong, Tamas L Horvath and 4 more

Abstract read
In one paragraph

Article in Science immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 178 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
178citing papers in PubMed, 2 pooled it
22.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

178 citing papers in PubMed, 2 syntheses or guidelines pooled it, 262 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Microbiota-dependent IFN-L controls uterine and placental immunity.bioRxiv : the preprint server for biology · 2026
    Article
  17. Article
  18. Review
  19. Review
  20. Review

118 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Laura J YockeyDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.ORCID 0000-0002-2437-6518
Kellie A JuradoDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Nitin AroraDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.
Alon MilletDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.ORCID 0000-0001-6514-0459
Tasfia RakibDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.ORCID 0000-0002-4581-2059
Kristin M MilanoDepartment of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520, USA.
Andrew K HastingsSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.ORCID 0000-0003-2488-9193
Erol FikrigSection of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.ORCID 0000-0002-5884-6047
Yong KongYale School of Public Health, New Haven, CT 06520, USA.ORCID 0000-0002-2881-5274
Tamas L HorvathProgram in Integrative Cell Signaling and Neurobiology of Metabolism, Section of Comparative Medicine New Haven, CT 06520, USA.
Scott WeatherbeeDepartment of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA.
Harvey J KlimanDepartment of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520, USA.ORCID 0000-0002-2151-7071
Carolyn B CoyneDepartment of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.ORCID 0000-0002-1884-6309
Akiko IwasakiDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA. akiko.iwasaki@yale.edu.ORCID 0000-0002-7824-9856
Yale University · USHoward Hughes Medical Institute · USUniversity of Pittsburgh · USIntegrative Medicine Institute · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
Systems investigation of vaccine responses in B cell depleted autoimmune patientsU19AI089992 · NIAID · YALE UNIVERSITY · PI David A. Hafler, RUTH R MONTGOMERY · 2010 to 2026
$50.4M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
INTERDISCIPLINARY IMMUNOLOGY TRAINING PROGRAMT32AI007019 · NIAID · YALE UNIVERSITY · PI Carrie L. Lucas, David G. Schatz · 1985 to 2026
$14.4M
Immunity to Genital Herpes Simplex-2R01AI054359 · NIAID · YALE UNIVERSITY · PI IWASAKI, AKIKO · 2004 to 2019
$5.2M
Molecular and Cellular Transport in MucusR01EB000487 · NIBIB · YALE UNIVERSITY · PI IWASAKI, AKIKO, SALTZMAN, W. MARK · 2002 to 2019
$5.0M
Primary human trophoblasts and the transfer of viral resistanceR01HD075665 · NICHD · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI COYNE, CAROLYN B, SADOVSKY, YOEL · 2012 to 2016
$2.4M
The role of NLRP6 and DHX15 in control of infection by RNA virusesR01AI127865 · NIAID · YALE UNIVERSITY · PI FIKRIG, EROL, FLAVELL, RICHARD A · 2018 to 2022
$2.1M
Innate antiviral defense against Vaginal transmission of ZIKA virusR21AI131284 · NIAID · YALE UNIVERSITY · PI IWASAKI, AKIKO · 2017 to 2018
$461k
Immune control of Zika virus after vaginal infectionF30HD094717 · NICHD · YALE UNIVERSITY · PI YOCKEY, LAURA JEANNETTE · 2017 to 2018
$54k
Howard Hughes Medical InstituteNCI NIH HHS P30 CA047904NIAID NIH HHS R01 AI054359NIAID NIH HHS R01 AI127865NIAID NIH HHS R21 AI131284NIAID NIH HHS T32 AI007019NIAID NIH HHS U19 AI089992NIBIB NIH HHS R01 EB000487NICHD NIH HHS F30 HD094717NICHD NIH HHS R01 HD075665NIGMS NIH HHS T32 GM007205
6 · The paper itself

Abstract

Zika virus (ZIKV) infection during pregnancy is associated with adverse fetal outcomes, including microcephaly, growth restriction, and fetal demise. Type I interferons (IFNs) are essential for host resistance against ZIKV, and IFN-α/β receptor (IFNAR)-deficient mice are highly susceptible to ZIKV infection. Severe fetal growth restriction with placental damage and fetal resorption is observed after ZIKV infection of type I IFN receptor knockout (

Indexed as

AnimalsDisease Models, AnimalFemaleFetal DeathFetal Growth RetardationFetusHumansInterferon Type IMaleMiceMice, Inbred C57BLPlacentaPregnancyPregnancy Complications, InfectiousReceptor, Interferon alpha-betaUterusInterferon Type IReceptor, Interferon alpha-beta

Identifiers

PMID29305462
PMCPMC6049088
OpenAlexW2781472954

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.